Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001705905-26-000008

Options or other derivatives

  • Chief Scientific Officer acquired 318,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Roberts M Scot · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-26 Grant or award : show line 1 in the form Stock Options (option to buy) +222,670 222,670 D
2026-02-26 Grant or award : show line 2 in the form Restricted Stock Units +95,430 95,430 D
Loading xslF345X05/form4-02272026_040203.xml…